Global Hematology Treatment Industry Research Report 2020, Forecast to 2025

June 2020 | 107 pages | ID: GE2B832A8AE9EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Scope of the Report

The Hematology Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Hematology Treatment is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Hematology Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Hematology Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Hematology Treatment market are discussed.

The market is segmented by types:

• Plasma Derived Factors
• Recombinant Factors

It can be also divided by applications:

• Hemophilia A
• Hemophilia B
• Von Wilebrand Disease
• Others

And this report covers the historical situation, present status and the future prospects of the global Hematology Treatment market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Takeda
• Celgene
• Bayer
• Biogen
• PRA Health Sciences
• Novo Nordisk
• Amgen
• Pfizer
• CSL Behring
• Alexion Pharma

Report Includes:

• xx data tables and xx additional tables
• An overview of global Hematology Treatment market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Hematology Treatment market
• Profiles of major players in the industry, including - Takeda, Celgene, Bayer, Biogen, PRA Health Sciences.....

Research objectives

• To study and analyze the global Hematology Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Hematology Treatment market by identifying its various subsegments.
• Focuses on the key global Hematology Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Hematology Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Hematology Treatment submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Hematology Treatment Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Hematology Treatment Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 HEMATOLOGY TREATMENT INDUSTRY OVERVIEW

2.1 Global Hematology Treatment Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Hematology Treatment Global Import Market Analysis
  2.1.2 Hematology Treatment Global Export Market Analysis
  2.1.3 Hematology Treatment Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Plasma Derived Factors
  2.2.2 Recombinant Factors
2.3 Market Analysis by Application
  2.3.1 Hemophilia A
  2.3.2 Hemophilia B
  2.3.3 Von Wilebrand Disease
  2.3.4 Others
2.4 Global Hematology Treatment Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Hematology Treatment Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Hematology Treatment Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Hematology Treatment Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Hematology Treatment Manufacturer Market Share
  2.4.5 Top 10 Hematology Treatment Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Hematology Treatment Market
  2.4.7 Key Manufacturers Hematology Treatment Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Hematology Treatment Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Hematology Treatment Industry Impact
  2.7.1 How the Covid-19 is Affecting the Hematology Treatment Industry
  2.7.2 Hematology Treatment Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Hematology Treatment Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Hematology Treatment Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL HEMATOLOGY TREATMENT MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Hematology Treatment Sales Market Share by Region
4.2 Global Hematology Treatment Revenue Market Share by Region (2015-2019)
4.3 Global Hematology Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Hematology Treatment Market Size Detail
  4.4.1 North America Hematology Treatment Sales Growth Rate (2015-2020)
  4.4.2 North America Hematology Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Hematology Treatment Market Size Detail
  4.5.1 Europe Hematology Treatment Sales Growth Rate (2015-2020)
  4.5.2 Europe Hematology Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Hematology Treatment Market Size Detail
  4.6.1 Japan Hematology Treatment Sales Growth Rate (2015-2020)
  4.6.2 Japan Hematology Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Hematology Treatment Market Size Detail
  4.7.1 China Hematology Treatment Sales Growth Rate (2015-2020)
  4.7.2 China Hematology Treatment Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL HEMATOLOGY TREATMENT MARKET SEGMENT BY TYPE

5.1 Global Hematology Treatment Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Hematology Treatment Sales and Market Share by Type (2015-2020)
  5.1.2 Global Hematology Treatment Revenue and Market Share by Type (2015-2020)
5.2 Plasma Derived Factors Sales Growth Rate and Price
  5.2.1 Global Plasma Derived Factors Sales Growth Rate (2015-2020)
  5.2.2 Global Plasma Derived Factors Price (2015-2020)
5.3 Recombinant Factors Sales Growth Rate and Price
  5.3.1 Global Recombinant Factors Sales Growth Rate (2015-2020)
  5.3.2 Global Recombinant Factors Price (2015-2020)

6 GLOBAL HEMATOLOGY TREATMENT MARKET SEGMENT BY APPLICATION

6.1 Global Hematology TreatmentSales Market Share by Application (2015-2020)
6.2 Hemophilia A Sales Growth Rate (2015-2020)
6.3 Hemophilia B Sales Growth Rate (2015-2020)
6.4 Von Wilebrand Disease Sales Growth Rate (2015-2020)
6.5 Others Sales Growth Rate (2015-2020)

7 GLOBAL HEMATOLOGY TREATMENT MARKET FORECAST

7.1 Global Hematology Treatment Sales, Revenue Forecast
  7.1.1 Global Hematology Treatment Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Hematology Treatment Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Hematology Treatment Price and Trend Forecast (2020-2025)
7.2 Global Hematology Treatment Sales Forecast by Region (2020-2025)
  7.2.1 North America Hematology Treatment Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Hematology Treatment Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Hematology Treatment Production, Revenue Forecast (2020-2025)
  7.2.4 China Hematology Treatment Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF HEMATOLOGY TREATMENT INDUSTRY KEY MANUFACTURERS

8.1 Takeda
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Takeda Hematology Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Takeda News
8.2 Celgene
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Celgene Hematology Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Celgene News
8.3 Bayer
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Bayer Hematology Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Bayer News
8.4 Biogen
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Biogen Hematology Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Biogen News
8.5 PRA Health Sciences
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 PRA Health Sciences Hematology Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 PRA Health Sciences News
8.6 Novo Nordisk
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Novo Nordisk Hematology Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Novo Nordisk News
8.7 Amgen
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Amgen Hematology Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Amgen News
8.8 Pfizer
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Pfizer Hematology Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Pfizer News
8.9 CSL Behring
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 CSL Behring Hematology Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 CSL Behring News
8.10 Alexion Pharma
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 Alexion Pharma Hematology Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 Alexion Pharma News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hematology Treatment Picture
Figure Research Programs/Design for This Report
Figure Global Hematology Treatment Market by Regions (2019)
Table Global Market Hematology Treatment Comparison by Regions (M USD) 2019-2025
Table Global Hematology Treatment Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Hematology Treatment by Type in 2019
Figure Plasma Derived Factors Picture
Figure Recombinant Factors Picture
Table Global Hematology Treatment Sales by Application (2019-2025)
Figure Global Hematology Treatment Sales Market Share by Application in 2019
Figure Hemophilia A Picture
Figure Hemophilia B Picture
Figure Von Wilebrand Disease Picture
Figure Others Picture
Table Global Hematology Treatment Sales by Manufacturer (2018-2020)
Figure Global Hematology Treatment Sales Market Share by Manufacturer in 2019
Table Global Hematology Treatment Revenue by Manufacturer (2018-2020)
Figure Global Hematology Treatment Revenue Market Share by Manufacturer in 2019
Table Global Hematology Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Hematology Treatment Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Hematology Treatment Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Hematology Treatment Market
Table Key Manufacturers Hematology Treatment Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hematology Treatment
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Hematology Treatment Sales (K Units) by Region (2015-2020)
Table Global Hematology Treatment Sales Market Share by Region (2015-2019)
Figure Global Hematology Treatment Sales Market Share by Region (2015-2019)
Figure Global Hematology Treatment Sales Market Share by Region in 2018
Table Global Hematology Treatment Revenue (Million US$) by Region (2015-2020)
Table Global Hematology Treatment Revenue Market Share by Region (2015-2020)
Figure Global Hematology Treatment Revenue Market Share by Region (2015-2020)
Figure Global Hematology Treatment Revenue Market Share by Region in 2019
Table Global Hematology Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Hematology Treatment Sales (K Units) Growth Rate (2015-2020)
Table North America Hematology Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Hematology Treatment Sales (K Units) Growth Rate (2015-2020)
Table Europe Hematology Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Hematology Treatment Sales (K Units) Growth Rate (2015-2020)
Table Japan Hematology Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Hematology Treatment Sales (K Units) Growth Rate (2015-2020)
Table China Hematology Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Hematology Treatment Sales by Type (2015-2020)
Table Global Hematology Treatment Sales Market Share by Type (2015-2020)
Figure Global Hematology Treatment Sales Market Share by Type in 2019
Table Global Hematology Treatment Revenue by Type (2015-2020)
Table Global Hematology Treatment Revenue Market Share by Type (2015-2020)
Figure Global Hematology Treatment Revenue Market Share by Type in 2019
Figure Global Plasma Derived Factors Sales Growth Rate (2015-2020)
Figure Global Plasma Derived Factors Price (2015-2020)
Figure Global Recombinant Factors Sales Growth Rate (2015-2020)
Figure Global Recombinant Factors Price (2015-2020)
Table Global Hematology Treatment Sales by Application (2015-2020)
Table Global Hematology Treatment Sales Market Share by Application (2015-2020)
Figure Global Hematology Treatment Sales Market Share by Application in 2019
Figure Global Hemophilia A Sales Growth Rate (2015-2020)
Figure Global Hemophilia B Sales Growth Rate (2015-2020)
Figure Global Von Wilebrand Disease Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Hematology Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Hematology Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Hematology Treatment Price and Trend Forecast (2020-2025)
Table Global Hematology Treatment Sales (K Units) Forecast by Region (2020-2025)
Figure Global Hematology Treatment Production Market Share Forecast by Region (2020-2025)
Figure North America Hematology Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Hematology Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Hematology Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Hematology Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Hematology Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Hematology Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Hematology Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Hematology Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Takeda Company Profile
Figure Hematology Treatment Product Picture and Specifications of Takeda
Table Hematology Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Takeda Hematology Treatment Market Share (2018-2020)
Table Takeda Main Business
Table Takeda Recent Development
Table Celgene Company Profile
Figure Hematology Treatment Product Picture and Specifications of Celgene
Table Hematology Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Celgene Hematology Treatment Market Share (2018-2020)
Table Celgene Main Business
Table Celgene Recent Development
Table Bayer Company Profile
Figure Hematology Treatment Product Picture and Specifications of Bayer
Table Hematology Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bayer Hematology Treatment Market Share (2018-2020)
Table Bayer Main Business
Table Bayer Recent Development
Table Biogen Company Profile
Figure Hematology Treatment Product Picture and Specifications of Biogen
Table Hematology Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biogen Hematology Treatment Market Share (2018-2020)
Table Biogen Main Business
Table Biogen Recent Development
Table PRA Health Sciences Company Profile
Figure Hematology Treatment Product Picture and Specifications of PRA Health Sciences
Table Hematology Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure PRA Health Sciences Hematology Treatment Market Share (2018-2020)
Table PRA Health Sciences Main Business
Table PRA Health Sciences Recent Development
Table Novo Nordisk Company Profile
Figure Hematology Treatment Product Picture and Specifications of Novo Nordisk
Table Hematology Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novo Nordisk Hematology Treatment Market Share (2018-2020)
Table Novo Nordisk Main Business
Table Novo Nordisk Recent Development
Table Amgen Company Profile
Figure Hematology Treatment Product Picture and Specifications of Amgen
Table Hematology Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Amgen Hematology Treatment Market Share (2018-2020)
Table Amgen Main Business
Table Amgen Recent Development
Table Pfizer Company Profile
Figure Hematology Treatment Product Picture and Specifications of Pfizer
Table Hematology Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer Hematology Treatment Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table CSL Behring Company Profile
Figure Hematology Treatment Product Picture and Specifications of CSL Behring
Table Hematology Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure CSL Behring Hematology Treatment Market Share (2018-2020)
Table CSL Behring Main Business
Table CSL Behring Recent Development
Table Alexion Pharma Company Profile
Figure Hematology Treatment Product Picture and Specifications of Alexion Pharma
Table Hematology Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Alexion Pharma Hematology Treatment Market Share (2018-2020)
Table Alexion Pharma Main Business
Table Alexion Pharma Recent Development
Table of Appendix